4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one,
CHIR 258,
CHIR-258,
CHIR258,
dovitinib,
TKI 258,
TKI-258,
TKI258,
692737-80-7,
Dovitinib lactate,
Dovitinib (TKI258) Lactate,
Dovitinib (lactate),
UNII-B82T791274,
4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydroxypropanoate,
4-AMINO-5-FLUORO-3-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZO-[D]IMIDAZOL-2-YL)QUINOLIN-2(1H)-ONE 2-HYDROXYPROPANOATE,
B82T791274,
Dovitinib lactate anhydrous,
TKI258,
TKI 258,
Dovitinib(lactate),
4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydroxy,
SCHEMBL253137,
CTK8B6779,
KS-00001CPY,
ZRHDKBOBHHFLBW-UHFFFAOYSA-N,
BCP04112,
BCP27905,
ANW-54336,
s7765,
AKOS015999848,
API0017254,
CS-6230,
SB20298,
4CA-1260,
HY-10207,
B5953,
4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactate,
Propanoic acid,2-hydroxy-,compd.with 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone,
Dovitinib lactate monohydrate,
TKI-258,
Dovitinib (TKI-258) Dilactic Acid,
CID11248671,
CID 11248671,
915769-50-5,
852433-84-2,